IBRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 83.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

ImmunityBio Insider Trading History Chart

ImmunityBio Share Price & Price History

^$2.94

▼ -0.075 (-2.49%)

As of 04/1/2025 03:48 PM ET

Days: 30 | 90 | 365

ImmunityBio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/5/2023	Michael D. Blaszyk	Director	Buy	71,915	$2.75	$197,766.25	71,915
6/2/2023	John Owen Brennan	Director	Buy	25,000	$2.83	$70,750.00	25,000

SEC Filings (Institutional Ownership Changes) for ImmunityBio (NASDAQ:IBRX)

8.58% of ImmunityBio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ImmunityBio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/19/2025	GF Fund Management CO. LTD.	14,632	$37K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	261,734	$0.67M	0.0%	-83.1%	0.038%
2/17/2025	Waverly Advisors LLC	14,762	$38K	0.0%	N/A	0.002%
2/17/2025	Woodline Partners LP	3,442,440	$8.81M	0.1%	+682.7%	0.494%
2/17/2025	Wexford Capital LP	33,113	$85K	0.0%	N/A	0.005%
2/17/2025	Two Sigma Investments LP	28,317	$72K	0.0%	N/A	0.004%
2/17/2025	Tang Capital Management LLC	2,814,192	$7.20M	0.5%	N/A	0.404%
2/17/2025	Rafferty Asset Management LLC	549,905	$1.41M	0.0%	+20.7%	0.079%
2/17/2025	ProShare Advisors LLC	73,773	$0.19M	0.0%	+7.7%	0.011%
2/17/2025	Nuveen Asset Management LLC	355,302	$0.91M	0.0%	-12.0%	0.051%
2/17/2025	Millennium Management LLC	234,078	$0.60M	0.0%	-79.0%	0.034%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	104,874	$0.27M	0.0%	+9.7%	0.015%
2/17/2025	Deutsche Bank AG	123,057	$0.32M	0.0%	-63.1%	0.018%
2/17/2025	Brevan Howard Capital Management LP	99,757	$0.26M	0.0%	N/A	0.014%
2/17/2025	BNP Paribas Financial Markets	34,988	$90K	0.0%	N/A	0.005%
2/17/2025	Ameriprise Financial Inc.	15,014	$38K	0.0%	N/A	0.002%
2/14/2025	Mercer Global Advisors Inc. ADV	37,006	$95K	0.0%	+29.2%	0.005%
2/14/2025	Northern Trust Corp	1,323,424	$3.39M	0.0%	+7.9%	0.190%
2/14/2025	Ghisallo Capital Management LLC	500,000	$1.28M	0.1%	N/A	0.072%
2/14/2025	Virtus ETF Advisers LLC	115,018	$0.29M	0.1%	+105.0%	0.017%
2/14/2025	Price T Rowe Associates Inc. MD	56,288	$0.15M	0.0%	-25.2%	0.008%
2/14/2025	Dark Forest Capital Management LP	25,144	$64K	0.0%	N/A	0.004%
2/14/2025	Hsbc Holdings PLC	16,840	$44K	0.0%	N/A	0.002%
2/14/2025	Tower Research Capital LLC TRC	50,799	$0.13M	0.0%	+1,010.1%	0.007%
2/14/2025	MetLife Investment Management LLC	89,393	$0.23M	0.0%	+43.3%	0.013%
2/14/2025	Dimensional Fund Advisors LP	27,966	$72K	0.0%	+154.0%	0.004%
2/14/2025	First Trust Advisors LP	167,200	$0.43M	0.0%	-77.9%	0.024%
2/14/2025	Altium Capital Management LLC	1,060,000	$2.71M	0.8%	N/A	0.152%
2/13/2025	Marshall Wace LLP	240,311	$0.62M	0.0%	N/A	0.034%
2/13/2025	XTX Topco Ltd	105,883	$0.27M	0.0%	+14.0%	0.015%
2/13/2025	Barclays PLC	396,484	$1.02M	0.0%	+9.8%	0.057%
2/13/2025	Raymond James Financial Inc.	67,354	$0.17M	0.0%	N/A	0.010%
2/13/2025	Capula Management Ltd	60,101	$0.15M	0.0%	N/A	0.009%
2/13/2025	Rathbones Group PLC	89,420	$0.23M	0.0%	+21.8%	0.013%
2/13/2025	Legal & General Group Plc	131,364	$0.34M	0.0%	-7.8%	0.019%
2/13/2025	Wells Fargo & Company MN	138,605	$0.36M	0.0%	+30.4%	0.020%
2/12/2025	Geode Capital Management LLC	3,840,918	$9.84M	0.0%	-0.1%	0.551%
2/12/2025	Franklin Resources Inc.	88,686	$0.23M	0.0%	-54.4%	0.013%
2/12/2025	Alliancebernstein L.P.	214,030	$0.55M	0.0%	+4.1%	0.031%
2/12/2025	Blair William & Co. IL	233,500	$0.60M	0.0%	+12.9%	0.034%
2/12/2025	JPMorgan Chase & Co.	1,041,863	$2.67M	0.0%	-8.7%	0.150%
2/11/2025	Corebridge Financial Inc.	71,967	$0.18M	0.0%	-7.0%	0.010%
2/11/2025	Vanguard Group Inc.	17,328,229	$44.36M	0.0%	+2.5%	2.487%
2/11/2025	LPL Financial LLC	257,449	$0.66M	0.0%	+67.2%	0.037%
2/11/2025	Fox Run Management L.L.C.	33,504	$86K	0.0%	N/A	0.005%
2/11/2025	KLP Kapitalforvaltning AS	22,100	$57K	0.0%	N/A	0.003%
2/11/2025	Teacher Retirement System of Texas	41,742	$0.11M	0.0%	+20.4%	0.006%
2/11/2025	Intech Investment Management LLC	105,386	$0.27M	0.0%	+54.7%	0.015%
2/10/2025	Clearwater Capital Advisors LLC	846,419	$2.17M	0.2%	+75.4%	0.121%
2/10/2025	Cibc World Markets Corp	13,546	$35K	0.0%	N/A	0.002%
2/10/2025	Corient Private Wealth LLC	222,380	$0.57M	0.0%	-50.2%	0.032%
2/10/2025	Copperwynd Financial LLC	20,087	$51K	0.0%	+99.1%	0.003%
2/10/2025	Commonwealth Equity Services LLC	28,955	$74K	0.0%	+40.7%	0.004%
2/10/2025	Skandinaviska Enskilda Banken AB publ	295,950	$0.79M	0.0%	+9.2%	0.042%
2/10/2025	Swiss National Bank	274,000	$0.70M	0.0%	+1.5%	0.039%
2/7/2025	HighTower Advisors LLC	30,095	$77K	0.0%	-17.8%	0.004%
2/7/2025	E Fund Management Co. Ltd.	38,900	$100K	0.0%	+32.9%	0.006%
2/6/2025	Raymond James Financial Inc.	67,354	$0.17M	0.0%	N/A	0.010%
2/6/2025	Charles Schwab Investment Management Inc.	1,276,673	$3.27M	0.0%	+0.8%	0.183%
2/6/2025	Schechter Investment Advisors LLC	15,000	$38K	0.0%	N/A	0.002%
2/6/2025	SBI Securities Co. Ltd.	22,677	$58K	0.0%	N/A	0.003%
2/5/2025	Maia Wealth LLC	14,396	$37K	0.0%	N/A	0.002%
2/4/2025	Bank of New York Mellon Corp	499,528	$1.28M	0.0%	-1.1%	0.072%
2/4/2025	Crestwood Advisors Group LLC	16,200	$41K	0.0%	N/A	0.002%
2/3/2025	Handelsbanken Fonder AB	92,300	$0.24M	0.0%	+71.2%	0.013%
2/3/2025	Private Advisor Group LLC	13,450	$34K	0.0%	-75.4%	0.002%
1/31/2025	New York State Common Retirement Fund	32,418	$83K	0.0%	+62.8%	0.005%
1/28/2025	Stephens Inc. AR	10,090	$26K	0.0%	N/A	0.001%
1/24/2025	China Universal Asset Management Co. Ltd.	147,754	$0.38M	0.0%	+10.3%	0.021%
1/22/2025	Wealth Effects LLC	73,700	$0.19M	0.1%	-18.6%	0.011%
1/17/2025	Mutual Advisors LLC	16,200	$41K	0.0%	N/A	0.002%
1/17/2025	Sheets Smith Wealth Management	633,975	$1.62M	0.2%	-4.8%	0.091%
12/26/2024	JPMorgan Chase & Co.	1,140,911	$4.24M	0.0%	-3.6%	0.164%
12/19/2024	Principal Financial Group Inc.	12,513	$47K	0.0%	-69.6%	0.002%
11/27/2024	Franklin Resources Inc.	194,442	$0.72M	0.0%	-2.4%	0.028%
11/25/2024	Sanctuary Advisors LLC	29,184	$0.11M	0.0%	-20.8%	0.004%
11/20/2024	Virtu Financial LLC	13,608	$51K	0.0%	N/A	0.002%
11/19/2024	Barclays PLC	361,036	$1.34M	0.0%	+127.4%	0.052%
11/16/2024	Geode Capital Management LLC	3,846,675	$14.31M	0.0%	-1.8%	0.552%
11/15/2024	Barclays PLC	361,036	$1.34M	0.0%	+127.4%	0.052%
11/15/2024	Continuum Advisory LLC	15,030	$56K	0.0%	-24.9%	0.002%
11/15/2024	XTX Topco Ltd	92,910	$0.35M	0.0%	+309.4%	0.013%
11/15/2024	State Street Corp	8,654,460	$32.20M	0.0%	+10.1%	1.243%
11/15/2024	HighTower Advisors LLC	36,612	$0.14M	0.0%	N/A	0.005%
11/14/2024	Verition Fund Management LLC	94,270	$0.35M	0.0%	+131.8%	0.014%
11/14/2024	Captrust Financial Advisors	11,073	$41K	0.0%	N/A	0.002%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,544,802	$5.75M	0.0%	-2.1%	0.222%
11/14/2024	MetLife Investment Management LLC	62,365	$0.23M	0.0%	-24.2%	0.009%
11/13/2024	FMR LLC	8,152	$30K	0.0%	-30.7%	0.001%
11/13/2024	Quantbot Technologies LP	38,412	$0.14M	0.0%	N/A	0.006%
11/13/2024	Advantage Alpha Capital Partners LP	69,207	$0.26M	0.1%	N/A	0.010%
11/12/2024	Charles Schwab Investment Management Inc.	1,265,981	$4.71M	0.0%	+2.4%	0.182%
11/9/2024	Intech Investment Management LLC	68,140	$0.25M	0.0%	N/A	0.010%
11/5/2024	GSA Capital Partners LLP	107,985	$0.40M	0.0%	+290.3%	0.016%
10/31/2024	Principal Financial Group Inc.	12,513	$47K	0.0%	-69.6%	0.002%
10/25/2024	China Universal Asset Management Co. Ltd.	133,966	$0.50M	0.1%	+64.9%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	25,192	$99K	0.0%	+22.0%	0.004%
10/22/2024	Courier Capital LLC	30,000	$0.11M	0.0%	+50.0%	0.004%
10/22/2024	Private Advisor Group LLC	54,767	$0.20M	0.0%	-37.0%	0.008%
10/21/2024	Wealth Effects LLC	90,500	$0.34M	0.1%	+3.4%	0.013%

Data available starting January 2016

See Full Table

ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Its platforms for the development of biologic product candidates include antibody-cytokine fusion proteins; DNA, RNA, and recombinant protein vaccines; and cell therapies. The company's platforms have generated therapeutic agents that are currently being or planned to be studied in clinical trials across various indications in liquid and solid tumors, including bladder, lung and colorectal cancers, and glioblastoma multiforme. Its lead biologic product candidate is Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute. It also has license agreements with 3M Innovative Properties Company; Access to Advanced Health Institute; LadRx Corporation; Sanford Health; Shenzhen Beike Biotechnology Co. Ltd.; Viracta Therapeutics, Inc.; and GlobeImmune, Inc. The company is based in San Diego, California.

Today's Range

Now: $2.94

$2.95

$3.26

50 Day Range

MA: $3.13

$2.71

$3.90

52 Week Range

Now: $2.94

$2.28

$10.53

Volume

4,656,356 shs

Average Volume

5,579,518 shs

Market Capitalization

$2.50 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of ImmunityBio?: ImmunityBio's top insider shareholders include:
Michael D Blaszyk (Director)
John Owen Brennan (Director)
Learn More about top insider investors at ImmunityBio.
Who are the major institutional investors of ImmunityBio?: ImmunityBio's top institutional shareholders include:
Vanguard Group Inc. — 2.49%
Geode Capital Management LLC — 0.55%
Woodline Partners LP — 0.49%
Tang Capital Management LLC — 0.40%
Northern Trust Corp — 0.19%
Charles Schwab Investment Management Inc. — 0.18%
Learn More about top institutional investors of ImmunityBio stock.
Which institutional investors are selling ImmunityBio stock?: Within the last quarter, IBRX stock was sold by these institutional investors:
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Millennium Management LLC
First Trust Advisors LP
Corient Private Wealth LLC
Deutsche Bank AG
Franklin Resources Inc.
JPMorgan Chase & Co.
Nuveen Asset Management LLC
Which institutional investors are buying ImmunityBio stock?: During the previous quarter, IBRX stock was purchased by institutional investors including:
Woodline Partners LP
Tang Capital Management LLC
Altium Capital Management LLC
Ghisallo Capital Management LLC
Vanguard Group Inc.
Clearwater Capital Advisors LLC
Affinity Asset Advisors LLC
Marshall Wace LLP
In the last year, these company insiders have bought ImmunityBio stock:
Michael D Blaszyk (Director)
John Owen Brennan (Director)
Learn More investors buying ImmunityBio stock.